Teva Pharma (TEVA) call put ratio 52 calls to 1 put into quarter results
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $36.36 -0.71%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) May weekly 14 straddle priced for a move of 7% into the expected release of quarter results before the bell on May 8.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva Pharma (TEVA) PT Raised to $48 at UBS
- Teva Pharma (TEVA) PT Raised to $48 at UBS
- Planet Labs (PL) call put ratio 2.1 calls to 1 put into quarter results
Create E-mail Alert Related Categories
Option EPS Action, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
